Synergism of the combinations of imipenem plus ciprofloxacin and imipenem plus amikacin against Pseudomonas aeruginosa and other bacterial pathogens.
AUTOR(ES)
Bustamante, C I
RESUMO
The combinations of imipenem plus ciprofloxacin and imipenem plus amikacin were investigated for their activity against Pseudomonas aeruginosa and other bacterial pathogens. For imipenem-susceptible P. aeruginosa, synergy of imipenem plus ciprofloxacin and imipenem plus amikacin was observed against 36 and 45% of the strains, respectively. The incidence of synergy against imipenem-resistant isolates of P. aeruginosa was 10% for both combinations. Antagonism was not observed with either combination.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=174794Documentos Relacionados
- Ciprofloxacin interactions with imipenem and amikacin against multiresistant Pseudomonas aeruginosa.
- Serum bactericidal activity and killing rate for volunteers receiving imipenem, imipenem plus amikacin, and ceftazidime plus amikacin against Pseudomonas aeruginosa.
- Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.
- Synergism of Imipenem and Amikacin in Combination with Other Antibiotics Against Nocardia asteroides
- Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides.